
Medication Quality Fiasco Hits Delhi Government Hospitals: Critical Drugs Fail Quality Tests/ Mint
Medication Quality Fiasco Hits Delhi Government Hospitals: Critical Drugs Fail Quality Tests
A disturbing revelation has emerged regarding the quality of life-saving drugs supplied to various government hospitals in Delhi. Shockingly, crucial medications vital for treating ailments like epilepsy, hypertension, infections, and even COVID-19 have reportedly failed mandatory quality standards.
Reports from both government and private labs revealed the failure of several drugs. Out of 43 samples tested in government labs, three failed, while 12 reports were still pending.
In private labs, five out of 43 samples failed quality tests, prompting the Vigilance Department’s recommendation to immediately halt the supply of these drugs to Delhi government hospitals.
The impacted drugs include widely used medications like Cephalexin for lung and urinary tract infections, Dexamethasone to address severe lung inflammation, Amlodipine for managing hypertension, Levetiracetam to treat epilepsy, and Pantoprazole for heartburn and reflux diseases. Sodium valproate, crucial for epilepsy management, was among those found to be spurious during quality examinations at the Regional Drug Testing Laboratory in Chandigarh.
In response to this alarming situation, Lieutenant Governor VK Saxena recommended a CBI investigation into the alleged supply of substandard drugs, emphasizing the risk these medications pose to patients’ lives in Delhi government hospitals.
The Directorate of Vigilance urged the health secretary to prevent payments to firms supplying these failed drugs, demanding immediate seizure and removal of these medications from hospital stocks.
Moreover, there’s a call for precise identification of the drugs and clarity on when they were procured for supply.
This critical situation demands swift action to safeguard the health and well-being of patients, underscoring the urgency to address and rectify the concerning quality lapses in the procurement and supply of essential medicines to Delhi government hospitals.
Latest Posts
- WhatsApp Puts Multiple Accounts ‘Under Review’, Blocks Access For 24 Hours
August 4, 2026 | Breaking News, Social Media - Centre Hikes Windfall Gains Tax On Export Of Petrol, Diesel Amid Iran War
August 4, 2026 | Breaking News, India - NEET Paper Leak Dominates Punjab Assembly Session, AAP Attacks BJP
August 4, 2026 | Breaking News, India, Politics - LIC Stake Sale Begins Tuesday; India Government Launches LIC OFS
August 4, 2026 | Breaking News, Business, India - Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook
August 3, 2026 | Breaking News, Business, Markets - Ukraine Removes US Ambassador Olha Stefanishyna From Post
August 3, 2026 | Breaking News, Politics, World - FSSAI Prohibits Sale of Dabur India Products Carrying Misleading ‘100%’ Claims
August 3, 2026 | Breaking News, Business, India - Citi hires Bank of America’s Rohan Sen to lead technology services banking
August 3, 2026 | Breaking News, World - UBS Fined $125 Million by US Regulators for Anti-Money Laundering Violations
August 3, 2026 | Breaking News, Business, Markets - SAS airline cabin crew in Norway plan to go on strike from August 8
August 3, 2026 | Breaking News, Business, Markets